[Drug resistance in antiretroviral therapy of HIV infection].

Abstract excerpt

Despite impressive success of highly active antiretroviral therapy, a durable control of viral replication cannot be achieved in a substantial proportion of HIV-infected patients. The most important reason is development of resistance, defined as capability of mutant virus to replicate in the presence of a higher concentration of substance in comparison to wild-type virus. In the treated HIV-positive population...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anti-HIV Agents
• Share to Antiretroviral Therapy, Highly Active
• Share to Clinical Trials as Topic